155 related articles for article (PubMed ID: 34231945)
1. Impact of prostate focused alignment on planned pelvic lymph node dose.
Kilian-Meneghin J; Ma T; Kumaraswamy L
J Appl Clin Med Phys; 2021 Jul; 22(7):27-35. PubMed ID: 34231945
[TBL] [Abstract][Full Text] [Related]
2. Retrospective audit of inter-fraction motion for pelvic node radiotherapy in prostate cancer patients.
Lawes R; Carter E; Hussein M; Murray J; McNair HA
Radiography (Lond); 2021 May; 27(2):266-271. PubMed ID: 32830012
[TBL] [Abstract][Full Text] [Related]
3. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
Marnouche EA; Hadadi K; Abdelhak M; Benlemlih M; Hommadi M; Zaghba N; Andaloussi Saghir K; Elmarjany M; Sifat H; Mansouri H
Cancer Radiother; 2021 Apr; 25(2):161-168. PubMed ID: 33454191
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?
Eminowicz G; Dean C; Shoffren O; Macdougall N; Wells P; Muirhead R
Br J Radiol; 2014 May; 87(1037):20130696. PubMed ID: 24646126
[TBL] [Abstract][Full Text] [Related]
6. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.
Cantin A; Gingras L; Lachance B; Foster W; Goudreault J; Archambault L
Med Phys; 2015 Dec; 42(12):7011-21. PubMed ID: 26632056
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
Yoo S; Wu QJ; Lee WR; Yin FF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric consequences of prostate-based couch shifts on the precision of dose delivery during simultaneous IMRT irradiation of the prostate, seminal vesicles and pelvic lymph nodes.
Adamczyk M; Piotrowski T; Adamiak E; Malicki J
Phys Med; 2014 Mar; 30(2):228-33. PubMed ID: 23860339
[TBL] [Abstract][Full Text] [Related]
10. Impact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.
Tyagi N; Hipp E; Cloutier M; Charas T; Fontenla S; Mechalakos J; Hunt M; Zelefsky M
J Appl Clin Med Phys; 2019 Jul; 20(7):121-127. PubMed ID: 31206236
[TBL] [Abstract][Full Text] [Related]
11. Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer.
Rossi PJ; Schreibmann E; Jani AB; Master VA; Johnstone PA
Radiother Oncol; 2009 Mar; 90(3):353-8. PubMed ID: 18952307
[TBL] [Abstract][Full Text] [Related]
12. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.
Su Z; Li Z; Henderson R; Hoppe B; Nichols RC; Bryant C; Mendenhall W; Mendenhall N
Phys Med Biol; 2019 Feb; 64(4):04NT04. PubMed ID: 30630135
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
[TBL] [Abstract][Full Text] [Related]
14. Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.
Harris VA; Staffurth J; Naismith O; Esmail A; Gulliford S; Khoo V; Lewis R; Littler J; McNair H; Sadoyze A; Scrase C; Sohaib A; Syndikus I; Zarkar A; Hall E; Dearnaley D;
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):874-83. PubMed ID: 26104940
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
[TBL] [Abstract][Full Text] [Related]
16. Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy.
Vees H; Dipasquale G; Nouet P; Zilli T; Cozzi L; Miralbell R
Technol Cancer Res Treat; 2015 Apr; 14(2):181-9. PubMed ID: 24694113
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of the benefit of fiducial image-guidance for prostate cancer intensity modulated radiation therapy using daily dose volume histogram analysis.
Kasaova L; Sirak I; Jansa J; Paluska P; Petera J
Technol Cancer Res Treat; 2014 Feb; 13(1):47-55. PubMed ID: 23819493
[TBL] [Abstract][Full Text] [Related]
18. Pelvic organ motion and dosimetric implications during horizontal patient rotation for prostate radiation therapy.
Buckley JG; Dowling JA; Sidhom M; Liney GP; Rai R; Metcalfe PE; Holloway LC; Keall PJ
Med Phys; 2021 Jan; 48(1):397-413. PubMed ID: 33151543
[TBL] [Abstract][Full Text] [Related]
19. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
20. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate.
Mayyas E; Kim J; Kumar S; Liu C; Wen N; Movsas B; Elshaikh MA; Chetty IJ
Med Phys; 2014 Sep; 41(9):091709. PubMed ID: 25186384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
